Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC Cohort

Colaboración

Año: 2018

Cramer, DW; Fichorova, RN; Terry, KL; Yamamoto, H; Vitonis, AF; Ardanaz, E; Aune, D; Boeing, H; Brandstedt, J; Boutron-Ruault, MC; Chirlaque, MD; Dorronsoro, M; Dossus, L; Duell, EJ; Gram, IT; Gunter, M; Hansen, L; Idahl, A; Johnson, T; Khaw, KT; Krogh, V; Kvaskoff, M; Mattiello, A; Matullo, G; Merritts, MA; Nodin, B; Orfanos, P; Onland-Moret, NC; Palli, D; Peppa, E; Quiros, JR; Sanchez-Perez, MJ; Severi, G; Tjonneland, A; Travis, RC; Trichopoulou, A; Tumino, R; Weiderpass, E; Fortner, RT; Kaaks, R

Título: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

• D1